Literature DB >> 20382905

Review of diabetes management and guidelines during Ramadan.

Muhammad Ali Karamat1, Ateeq Syed, Wasim Hanif.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20382905      PMCID： PMC2853405          DOI： 10.1258/jrsm.2010.090254

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  24 in total

1.  Fasting and insulin glargine in individuals with type 1 diabetes.

Authors:  Gregory T Mucha; Stacia Merkel; William Thomas; John P Bantle
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

2.  A study of the fasting diabetic patients during the month of Ramadan.

Authors:  M Mafauzy; W B Mohammed; M Y Anum; A Zulkifli; A H Ruhani
Journal:  Med J Malaysia       Date:  1990-03

3.  Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group.

Authors:  J Akram; V De Verga
Journal:  Diabet Med       Date:  1999-10       Impact factor: 4.359

4.  Treatment of type 1 diabetes with insulin lispro during Ramadan.

Authors:  A Kadiri; A Al-Nakhi; S El-Ghazali; A Jabbar; M Al Arouj; J Akram; J Wyatt; A Assem; S Ristic
Journal:  Diabetes Metab       Date:  2001-09       Impact factor: 6.041

5.  Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.

Authors:  M Mafauzy
Journal:  Diabetes Res Clin Pract       Date:  2002-10       Impact factor: 5.602

6.  A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.

Authors:  Ibrahim Salti; Eric Bénard; Bruno Detournay; Monique Bianchi-Biscay; Corinne Le Brigand; Céline Voinet; Abdul Jabbar
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

7.  The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan.

Authors:  Ramazan Sari; Mustafa Kemal Balci; Sadika Halide Akbas; Berkant Avci
Journal:  Endocr Res       Date:  2004-05       Impact factor: 1.720

8.  Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes.

Authors:  Sh Yarahmadi; B Larijani; M H Bastanhagh; M Pajouhi; R Baradar Jalili; F Zahedi; K Zendehdel; S M Akrami
Journal:  J Coll Physicians Surg Pak       Date:  2003-06       Impact factor: 0.711

9.  Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.

Authors:  E Ferrannini; V Fonseca; B Zinman; D Matthews; B Ahrén; S Byiers; Q Shao; S Dejager
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

Review 10.  Diabetes in Ramadan.

Authors:  Bashir Qureshi
Journal:  J R Soc Med       Date:  2002-10       Impact factor: 18.000
View more
  20 in total

Review 1.  The diabetic patient in Ramadan.

Authors:  Hassan Chamsi-Pasha; Khalid S Aljabri
Journal:  Avicenna J Med       Date:  2014-04

Review 2.  Ethical conflicts in the treatment of fasting Muslim patients with diabetes during Ramadan.

Authors:  Ilhan Ilkilic; Hakan Ertin
Journal:  Med Health Care Philos       Date:  2017-12

3.  Community pharmacists' knowledge of diabetes management during Ramadan in Egypt.

Authors:  Mohamed E K Amin; Betty Chewning
Journal:  Int J Clin Pharm       Date:  2014-09-25

4.  Assessing the awareness and care of people with diabetes related to Ramadan fasting; a-cross sectional study from Pakistan.

Authors:  Muhammad Yakoob Ahmedani; Maheen Siddique
Journal:  J Diabetes Metab Disord       Date:  2019-12-13

5.  The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.

Authors:  S Al Sifri; A Basiounny; A Echtay; M Al Omari; I Harman-Boehm; G Kaddaha; K Al Tayeb; A S Mahfouz; A Al Elq; L Radican; C Ozesen; H L Katzeff; B J Musser; S Suryawanshi; C J Girman; M J Davies; S S Engel
Journal:  Int J Clin Pract       Date:  2011-09-27       Impact factor: 2.503

6.  Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.

Authors:  Mohamed A Almaatouq
Journal:  Diabetes Metab Syndr Obes       Date:  2012-05-01       Impact factor: 3.168

7.  Recommendations for management of diabetes during Ramadan: update 2015.

Authors:  Mahmoud Ibrahim; Megahed Abu Al Magd; Firas A Annabi; Samir Assaad-Khalil; Ebtesam M Ba-Essa; Ibtihal Fahdil; Sehnaz Karadeniz; Terry Meriden; Aly A Misha'l; Paolo Pozzilli; Samad Shera; Abraham Thomas; Suhad Bahijri; Jaakko Tuomilehto; Temel Yilmaz; Guillermo E Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2015-06-16

8.  Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran.

Authors:  Ensieh Nasli-Esfahani; Maryam Peimani; Camelia Rambod; Maryam Omidvar; Bagher Larijani
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

9.  Having diabetes and having to fast: a qualitative study of British Muslims with diabetes.

Authors:  Neesha R Patel; Anne Kennedy; Christian Blickem; Anne Rogers; David Reeves; Carolyn Chew-Graham
Journal:  Health Expect       Date:  2014-01-20       Impact factor: 3.377

10.  Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries.

Authors:  Philip Home; Jihad Haddad; Zafar Ahmed Latif; Pradana Soewondo; Youcef Benabbas; Leon Litwak; Serdar Guler; Jian-Wen Chen; Alexey Zilov
Journal:  Diabetes Ther       Date:  2013-05-04       Impact factor: 2.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.